REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
Clinical trial NCT03951831 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03951831
- Sponsor
- Mark Stein
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-16
- Primary completion
- 2026-11-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.